Marabelle, A, Cassier, P A, Fakih, M, Kao, S, Nielsen, D, Italiano, A, Guren, T K, van Dongen, M G J, Spencer, K, Bariani, G M, Ascierto, P A, Santoro, A, Shah, M, Asselah, J, Iqbal, S, Takahashi, S, Piha-Paul, S A, Ott, P A, Chatterjee, A, Jin, F, Norwood, K & Delord, J P 2022, ' Pembrolizumab for previously treated advanced anal squamous cell carcinoma : results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 5, pp. 446-454 . https://doi.org/10.1016/S2468-1253(21)00382-4